AI Identifies New Potential Treatments For Parkinson ’s Disease
AI and machine learning techniques can be used to speed up the discovery of new drug candidates for serious diseases like Parkinson's and cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 18, 2024 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Innovation Rx: Technologies /feature/innovation-rx/technologies pharma & standard Source Type: news

Drugs Like Ozempic And Mounjaro Could Treat Other Conditions —Here’s What Scientists Are Looking At
GLP-1 drugs like Ozempic, Mounjaro, Zepbound and Wegovy are being explored for treating an array of conditions including sleep apnea, kidney disease, addiction, Parkinson ’s and Alzheimer’s. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 18, 2024 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Science /science Healthcare /healthcare Breaking breaking-news topline Source Type: news

Norton Healthcare receives $20M donation aimed at Parkinson's disease
The gift is from the estate of Dr. Elizabeth Park Cressman to Norton ’s “Just Imagine” campaign. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 17, 2024 Category: Biotechnology Authors: Joel Stinnett Source Type: news

Sage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark
said Wednesday its Parkinson's treatment failed in a midstage study. Sage stock collapsed to a record low. Wedbush analyst Laura Chico says it's hard to tell whether the drug failed because of the drug, the goals of the study, the disease or a mix of all three. Sage is still testing that drug,…#wedbush #laurachico #huntington #barrygreene #chico #allisongatlin #ibdagatlin (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2024 Category: Consumer Health News Source Type: news

Precision medicine for Parkinson ’s Disease is focus of new Yale center
Led by Yale researcher Clemens Scherzer, the center will leverage genomics and artificial intelligence to develop tailored therapeutics for the disease. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 16, 2024 Category: Universities & Medical Training Source Type: news

AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson & #039;s disease
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, on Sunday April 14 presented results from the 18-month Phase Ib clinical trial for AB-1005, an investigational gene therapy for treating patients with Parkinson's disease (PD).(1,2) The data were presented at the American Academy of Neurology 2024 Annual Meeting in Denver, Colorado, USA. The study met its primary objective, which was to evaluate the safety of a one-time bilateral delivery of AB-1005 directly to the putamen. (Source: World Pharma News)
Source: World Pharma News - April 16, 2024 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Predicting depression in Parkinson's disease using commonly available PD questionnaires - Camerucci E, Lyons KE, Pahwa R.
BACKGROUND: Depression is common in patients with Parkinson's disease (PD) and significantly impacts both the patients and their caregivers. The associations between depression and the responses from commonly used questionnaires for PD patients were assess... (Source: SafetyLit)
Source: SafetyLit - April 15, 2024 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Effectiveness of deep brain stimulation in improving balance in Parkinson's disease: a systematic review and meta-analysis - Morton A, Fraser H, Green C, Drovandi A.
INTRODUCTION: Balance dysfunction is a debilitating feature of advanced Parkinson's disease (PD), potentially improved by deep brain stimulation (DBS). This systematic review and meta-analysis pooled evidence from randomized controlled trials (RCT) on DBS ... (Source: SafetyLit)
Source: SafetyLit - April 15, 2024 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Recognizing symptoms of Parkinson's disease
April is Parkinson ’s Disease Awareness Month, which make this a good time to learn about the symptoms of Parkinson's disease. An estimated 1 million people in the U.S. and more than 10 million people worldwide are living with Parkinson's disease, according to the American Parkinson Disease Association. Parkinson's disease is a progressive nervous system disorder that affects movement. Parkinson's disease signs and symptoms can be different for everyone. Early signs may be mild and go unnoticed.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 13, 2024 Category: Databases & Libraries Source Type: news

h2o Therapeutics' Apple Watch feature for Parkinson's gets FDA medical device listing
The feature provides vibrotactile stimulation when a patient is experiencing freezing of gait, a common symptom of Parkinson ' s disease. (Source: mobihealthnews)
Source: mobihealthnews - April 12, 2024 Category: Information Technology Source Type: news

Diabetes drug shows potential in treating Parkinson ’s disease
A medicine for type 2 diabetes may slow the progression of the symptoms of Parkinson’s disease, research has suggested. Investigators evaluating the glucagon-like peptide 1 receptor agonist (GLP-1 RA) lixisenatide reported less progression of motor disability over a 12-month period in patients taking the drug compared with placebo. But writing in the New England Journal of Medicine, they... Read moreThe post Diabetes drug shows potential in treating Parkinson’s disease appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - April 12, 2024 Category: Nursing Authors: Megan Ford Tags: Clinical Diabetes Latest news Source Type: news

Toronto band behind '80s hit releases song on Parkinson's disease
Two members of a Toronto new wave band behind a 1980 international hit have released new music, this time to raise awareness of Parkinson's disease. (Source: CBC | Health)
Source: CBC | Health - April 12, 2024 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news

Toronto band behind 80s hit releases song on Parkinson's disease
Two members of a Toronto new wave band behind a 1980 international hit have released new music, this time to raise awareness of Parkinson's disease. (Source: CBC | Health)
Source: CBC | Health - April 12, 2024 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news

Paxman: Parkinson's makes you wish you'd not been born
The former University Challenge presenter delivers a list of recommendations to Downing Street. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 12, 2024 Category: Consumer Health News Source Type: news

Jeremy Paxman says Parkinson ’s ‘makes you wish you hadn’t been born’
Jeremy Paxman has said Parkinson’s disease “makes you wish you hadn’t been born” as he delivered a list of recommendations about the condition to Downing Street. The former University Challenge and Newsnight presenter and fellow members of the Movers and Shakers podcast – which discusses the…#jeremypaxman #downingstreet #universitychallenge #newsnight #movers #shakers #worldparkinsonsday #parkycharter #paxman #nhs (Source: Reuters: Health)
Source: Reuters: Health - April 11, 2024 Category: Consumer Health News Source Type: news